News New Vertex drugs could help 90% of cystic fibrosis patients Vertex soars after news that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time.
News AZ's asthma drug Fasenra approved in EU A further 3,400 children are eligible for treatment with Orkambi
News Promise of CF combinations lifts Vertex, reignites takeover ... Encouraging results from three pipeline combination therapies suggests Vertex could extend treatment to patients with more severe and difficult to treat cystic fibrosis.
News FDA chief nominee Gottlieb reveals industry links Scott Gottlieb, president Donald Trump’s nomination for FDA commissioner has revealed his close links with pharma.
News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Outlook bright for Vertex despite European delays But analysts excited by promise of next generation of medicines.
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
